Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. covers the month of April 2026. The report addresses the Company's compliance status with The Nasdaq Stock Market LLC regarding the minimum bid price requirement for its ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance regarding stock listing standards rather than financial performance.
Material Changes
The primary material change reported is the resolution of a listing deficiency. On March 11, 2026, the Company received notice of non-compliance with Nasdaq Listing Rule 5450(a)(1) due to a closing bid price below $1.00 for 30 consecutive business days. On April 27, 2026, Nasdaq confirmed that the Company regained compliance after maintaining a closing bid price of $1.00 or greater for 10 consecutive business days (April 13 to April 24, 2026).
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operations, or specific risk factors beyond the previously disclosed listing issue. The matter regarding the minimum bid price requirement is now closed.
Investor Verification Checklist
- Verify the current trading price of InflaRx N.V. ordinary shares to ensure continued compliance with Nasdaq Listing Rule 5450(a)(1).
- Review the attached Press Release (Exhibit 99.1) for any additional context regarding the stock price recovery.
- Confirm that no further compliance periods or warnings have been issued by Nasdaq subsequent to April 27, 2026.